218 related articles for article (PubMed ID: 91323)
1. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
[TBL] [Abstract][Full Text] [Related]
2. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
Geokas MC; Largman C; Brodrick JW; Johnson JH
Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
[TBL] [Abstract][Full Text] [Related]
3. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
5. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Carrère J; Chazalette JP; Figarella C
Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
[TBL] [Abstract][Full Text] [Related]
6. A method for determination of immunoreactive trypsin in complex with alpha 1-antitrypsin in human sera.
Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1984 Sep; 44(5):381-6. PubMed ID: 6333064
[TBL] [Abstract][Full Text] [Related]
7. Immunoenzymometric determination of trypsin/alpha 1-protease inhibitor complex in plasma of rats with experimental pancreatitis.
Fletcher TS; Tsukamoto H; Largman C
Clin Chem; 1986 Sep; 32(9):1738-41. PubMed ID: 3527480
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
[TBL] [Abstract][Full Text] [Related]
9. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
10. Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
Fabris C; Del Favero G; Panucci A; Plebani M; Di Mario F; Piccoli A; Basso D; Burlina A; Naccarato R
Enzyme; 1986; 35(2):82-6. PubMed ID: 2427333
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
Mero M; Tenhunen R; Pessi T; Sandholm M
Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
[TBL] [Abstract][Full Text] [Related]
12. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.
Kemppainen E; Hedström J; Puolakkainen P; Halttunen J; Sainio V; Haapiainen R; Kivilaakso E; Stenman UH
Gut; 1997 Nov; 41(5):690-5. PubMed ID: 9414980
[TBL] [Abstract][Full Text] [Related]
13. Human cationic, pancreatic elastase in acute pancreatitis.
Håkansson HO; Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1993 Feb; 53(1):17-24. PubMed ID: 7680823
[TBL] [Abstract][Full Text] [Related]
14. Studies on the activation of canine trypsinogens in vitro.
Borgström A; Ohlsson K
Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
[TBL] [Abstract][Full Text] [Related]
15. Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats.
Largman C; Reidelberger RD; Tsukamoto H
Dig Dis Sci; 1986 Sep; 31(9):961-9. PubMed ID: 3488185
[TBL] [Abstract][Full Text] [Related]
16. Serum phospholipase A2, immunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis.
Mero M; Schröder T; Tenhunen R; Lempinen M
Scand J Gastroenterol; 1982 Apr; 17(3):413-6. PubMed ID: 6182606
[TBL] [Abstract][Full Text] [Related]
17. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay.
Largman C; Brodrick JW; Geokas MC; Johnson JH
Biochim Biophys Acta; 1978 Nov; 543(4):450-4. PubMed ID: 718983
[TBL] [Abstract][Full Text] [Related]
19. Plasma immunoreactive-trypsin(ogen) levels during development.
Levine JJ; Udall JN; Bloch KJ; Hanson DG; James BC; Walker WA
J Pediatr Gastroenterol Nutr; 1988; 7(3):406-10. PubMed ID: 3260281
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases.
Kitahara T; Takatsuka Y; Fujimoto KI; Tanaka S; Ogawa M; Kosaki G
Clin Chim Acta; 1980 Apr; 103(2):135-43. PubMed ID: 6154549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
